Fennec Pharmaceuticals Inc

FENC · NASDAQ · Healthcare / Biotechnology

11.62USD+0.72 (+6.61%)

Price History

Full chart

Market Stats

Previous Close10.90

Open11.12

Day Range10.92 – 12.13

52-Week Range5.65 – 13.25

Volume461.31K

Market Cap372.41M

P/E (TTM)0.00

Forward P/E10.57

EPS-0.12

Dividend Yield0.00%

Beta1.10

50-Day Avg11.10

200-Day Avg8.84

About

Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Jeffrey S. Hackman
Employees35
Headquarters68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709, USA
Websitehttps://www.fennecpharma.com

Leadership

Mr. Jeffrey S. HackmanCEO & Director · b. 1963
Mr. Robert C. AndradeChief Financial Officer · b. 1975
Dr. Pierre S. Sayad M.S., Ph.D.Chief Medical Officer
Mr. Terry EvansChief Commercial Officer
Ms. Christiana Cioffi M.B.A.Chief Strategy Officer
Mr. Mark GowlandController
Mr. Lei FangPresident of Pharstat Inc

Financials

Income Statement

Currency: USD	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	0.68	0.66	0	0	0	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	170.00K	170.00K	1.53M	21.25M	47.54M	44.64M
Growth (%)	-	-2.94%	-100.00%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00%	+802.94%	+1284.50%	+123.69%	-6.09%
Cost of Revenue	-55.23K	-55.23K	0	0	0	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	-	0	86.00K	1.26M	3.18M	3.76M
Gross Profit	55.23K	55.23K	0	0	0	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	170.00K	0	1.45M	19.99M	44.35M	40.88M
Gross Margin	8122647.06%	8368787.88%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	100.00%	0.00%	94.40%	94.08%	93.30%	91.57%
Operating Expense	2.70M	2.70M	4.04M	6.74M	9.42M	-	-	-	-	-	-	3.44M	3.62M	1.93M	2.88M	1.89M	2.87M	6.95M	10.41M	-	18.05M	17.22M	24.19M	33.05M	41.88M	47.22M
Operating Income	-2.65M	-2.65M	-4.04M	-6.74M	-9.42M	-18.35M	-19.06M	-14.19M	-13.89M	-3.22M	-4.60M	-3.44M	-3.62M	-1.93M	-2.88M	-1.89M	-2.87M	-6.95M	-10.41M	-13.01M	-17.89M	-17.22M	-22.74M	-13.06M	2.48M	-6.35M
Operating Margin	-389533382.35%	-401337457.58%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-10520.59%	-10131.18%	-1481.30%	-61.44%	5.21%	-14.22%
EBITDA	-2.59M	-2.79M	-4.24M	-5.22M	-12.56M	-19.27M	-17.91M	-14.19M	-13.89M	-2.60M	-4.60M	4.55M	-5.18M	1.79M	-2.07M	-606.94K	82.00K	-95.00K	521.00K	-12.95M	-18.10M	-17.22M	-22.59M	-12.36M	4.80M	-7.45M
EBITDA Margin	-381410735.29%	-422388403.03%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-10647.06%	-10129.41%	-1471.47%	-58.18%	10.09%	-16.69%
Net Income	-2.45M	-2.45M	-3.72M	-6.15M	-8.74M	-19.25M	-19.10M	-13.36M	-13.60M	-3.01M	-7.82M	4.68M	-5.16M	1.84M	-2.18M	-659.00K	-2.79M	-7.05M	-9.89M	-12.46M	-18.11M	-17.35M	-23.71M	-16.05M	-436.00K	-9.74M
Net Income Margin	-360979117.65%	-371917890.91%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-10652.35%	-10203.53%	-1544.89%	-75.50%	-0.92%	-21.82%
R&D	1.91M	1.91M	3.13M	3.55M	3.59M	12.44M	14.00M	10.91M	10.37M	2.11M	708.00K	1.49M	2.08M	597.00K	357.00K	256.00K	472.00K	1.94M	5.01M	5.61M	5.11M	4.98M	3.53M	56.00K	307.00K	250.00K
R&D as % of Total Revenue	280898382.35%	289410454.55%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3002.94%	2930.00%	230.03%	0.26%	0.65%	0.56%
Interest Expense	0	0	0	0	444.00K	11.00K	3.00K	0	0	0	0	0	0	0	2.00K	0	0	0	0	0	9.00K	126.00K	978.00K	3.39M	4.07M	2.08M
Interest Expense % of Total Revenue	0.00%	0.00%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.29%	74.12%	63.71%	15.97%	8.56%	4.66%

Balance Sheet

Currency: USD	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	643.19K	10.46M	6.82M	25.66M	41.73M	28.45M	16.58M	17.21M	6.06M	833.00K	5.99M	5.35M	2.37M	1.75M	2.37M	1.02M	3.97M	28.40M	22.95M	14.15M	31.42M	22.41M	26.94M	26.86M	44.95M	70.07M
Total Liabilities	596.46K	635.41K	736.04K	10.35M	8.73M	8.39M	9.00M	3.06M	3.01M	427.00K	10.92M	5.47M	7.32M	3.21M	1.76M	471.00K	402.00K	1.64M	1.64M	2.27M	2.35M	6.64M	29.51M	38.49M	50.82M	35.02M
Total Equity	46.73K	9.82M	6.08M	15.31M	33.00M	20.06M	7.58M	14.15M	3.05M	406.00K	-4.92M	-120.00K	-4.96M	-1.46M	613.00K	548.00K	3.57M	26.76M	21.31M	11.88M	29.07M	15.77M	-2.57M	-11.62M	-5.87M	35.05M
Cash	111.12K	9.35M	207.06K	2.15M	13.67M	11.97M	5.67M	16.16M	5.35M	685.00K	5.95M	5.30M	2.30M	1.66M	2.31M	942.00K	3.93M	28.26M	22.78M	13.65M	30.34M	21.10M	23.77M	13.27M	26.63M	36.72M
Total Debt	59.00K	33.41K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.00M	24.90M	30.95M	19.34M	-
Net Debt	-52.12K	-9.32M	-207.06K	-2.15M	-13.67M	-11.97M	-5.67M	-16.16M	-5.35M	-685.00K	-5.95M	-5.30M	-2.30M	-1.66M	-2.31M	-942.00K	-3.93M	-28.26M	-22.78M	-13.65M	-30.34M	-16.11M	1.13M	17.68M	-7.29M	-36.72M

Cash Flow

Currency: USD	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-1.22M	-2.69M	-3.23M	-5.43M	-5.99M	-12.26M	-13.47M	-13.30M	-10.81M	-4.69M	-1.93M	-3.23M	-2.99M	-2.21M	-1.70M	-1.86M	-2.12M	-3.64M	-7.83M	-9.06M	-15.60M	-14.22M	-18.06M	-17.14M	26.98M	-12.47M
Investing Cash Flow	-32.32K	-323.20K	-5.80M	5.11M	-7.07M	-1.25M	1.17M	-75.00K	-15.00K	24.00K	-	-1.48M	-	0	0	0	0	0	-	-	-	-	-	-	-	-
Financing Cash Flow	1.28M	12.25M	-33.34K	2.24M	24.56M	7.96M	6.05M	23.88M	7.00K	-	7.19M	2.57M	-	1.57M	2.34M	497.00K	5.11M	27.98M	2.35M	-71.00K	32.29M	4.98M	20.73M	6.64M	-13.62M	22.63M
Capital Expenditure	32.32K	331.60K	298.72K	69.79K	155.12K	102.00K	5.00K	73.00K	15.00K	0	0	1.44M	0	0	0	0	0	0	0	0	0	0	0	2.75	0	0
Free Cash Flow	-1.26M	-3.02M	-3.53M	-5.50M	-6.14M	-12.36M	-13.48M	-13.38M	-10.82M	-4.69M	-1.93M	-3.23M	-2.99M	-2.21M	-1.70M	-1.86M	-2.12M	-3.64M	-7.83M	-9.06M	-15.60M	-14.22M	-18.06M	-17.14M	26.98M	-12.47M
Dividends Paid	0	0	0	0	0	-	-	-	-	-	-	0	-	0	0	0	0	0	-	-	-	-	529.16K	-	-	-
FCF to OCF	102.64%	112.33%	109.25%	101.28%	102.59%	100.83%	100.04%	100.55%	100.14%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Dividend Paid to FCF	0.00%	0.00%	0.00%	0.00%	0.00%	-	-	-	-	-	-	0.00%	-	0.00%	0.00%	0.00%	0.00%	0.00%	-	-	-	-	-2.93%	-	-	-

Earnings

Report Date	Dec 31, 2004	Aug 10, 2005	Nov 7, 2005	May 15, 2006	Aug 9, 2006	Nov 13, 2006	Mar 26, 2007	May 15, 2007	Aug 9, 2007	Nov 7, 2007	Mar 28, 2008	May 13, 2008	Aug 13, 2008	Nov 12, 2008	Mar 30, 2009	May 15, 2009	Aug 12, 2009	Nov 16, 2009	May 14, 2010	Aug 13, 2010	Nov 15, 2010	Mar 2, 2011	May 13, 2011	Aug 12, 2011	Nov 14, 2011	Feb 29, 2012	May 11, 2012	Aug 10, 2012	Nov 12, 2012	Feb 27, 2013	May 13, 2013	Aug 9, 2013	Nov 15, 2013	May 9, 2014	Aug 13, 2014	Nov 12, 2014	Mar 30, 2015	May 15, 2015	Aug 11, 2015	Nov 12, 2015	Mar 28, 2016	May 12, 2016	Aug 12, 2016	Nov 14, 2016	May 12, 2017	Aug 11, 2017	Nov 13, 2017	Mar 28, 2018	May 14, 2018	Aug 13, 2018	Nov 13, 2018	Mar 13, 2019	May 9, 2019	Aug 9, 2019	Nov 12, 2019	Feb 14, 2020	May 14, 2020	Aug 5, 2020	Nov 16, 2020	Mar 30, 2021	May 13, 2021	Aug 10, 2021	Nov 10, 2021	Feb 28, 2022	May 12, 2022	Aug 12, 2022	Nov 11, 2022	Mar 29, 2023	May 11, 2023	Aug 3, 2023	Nov 6, 2023	Mar 21, 2024	May 14, 2024	Aug 13, 2024	Nov 7, 2024	Mar 10, 2025	May 13, 2025	Aug 14, 2025	Nov 13, 2025	Mar 24, 2026	Apr 1, 2026	Aug 11, 2026	Nov 12, 2026
EPS Estimate	-	-	-6.48	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.05	-0.04	-0.14	-0.11	-0.09	-0.14	-0.14	-0.14	-0.13	-0.19	-0.11	-0.18	-0.17	-0.19	-0.19	-0.38	-0.18	-0.14	0.75	-0.14	-0.13	-0.19	-0.26	-0.19	-0.16	-0.13	-0.02	-0.04	0.02	-0.08	-0.13	-0.08	-0.03	-0.02	0.04	0.03	0.01	0.09
EPS Actual	-13.00	-5.49	-5.94	-4.48	-4.81	-5.35	-7.24	-2.60	-1.35	-1.35	-1.01	-1.81	-1.45	-1.37	-1.08	-0.95	-0.40	-0.01	-0.15	-0.48	0.25	-1.23	0.56	-0.04	-0.52	0.44	0.32	-0.07	-0.09	-0.78	-0.49	0.77	-0.21	-0.33	-0.08	0.03	0.14	0.01	-0.02	-0.01	-0.05	-0.04	-0.06	-0.04	-0.08	-0.11	-0.15	-0.14	-0.09	-0.14	-0.14	-0.15	-0.13	-0.24	-0.09	-0.18	-0.19	-0.21	-0.24	-0.13	-0.19	-0.15	-0.16	-0.18	-0.14	-0.19	-0.31	-0.26	-0.23	-0.21	-0.07	-0.10	0.41	-0.20	-0.21	-0.06	-0.04	-0.11	-0.02	-0.10	0.01	0.05	-
Surprise	-	-	8.33%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-120.00%	-275.00%	0.00%	18.18%	-55.56%	0.00%	-7.14%	7.14%	-84.62%	52.63%	-63.64%	-5.56%	-23.53%	-26.32%	31.58%	50.00%	16.67%	-14.29%	-124.00%	0.00%	-46.15%	-63.16%	0.00%	-21.05%	-31.25%	46.15%	-400.00%	1125.00%	-1100.00%	-162.50%	53.85%	50.00%	-266.67%	0.00%	-350.00%	-70.24%	400.00%	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	Pre-market	After-hours	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	After-hours	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	After-hours	Pre-market	-	Pre-market	Pre-market

Key Statistics & Ratios

Market Cap372.41M

Enterprise Value344.62M

Trailing P/E0.00

Forward P/E10.57

PEG Ratio1.47

Price / Sales6.29

Price / Book8.68

EPS-0.12

Book Value1.21

Revenue (TTM)59.22M

Gross Profit (TTM)55.51M

EBITDA-1.02M

Profit Margin-5.49%

Operating Margin9.72%

Return on Equity-18.58%

Return on Assets-1.17%

Shares Outstanding35.07M

Shares Float19.88M

Beta1.10

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Strong Buy

Based on 5 analystsTarget 17.67

Strong Buy
3
Buy
2

Ownership Breakdown

Institutions: 54.36%
Insiders: 14.12%
Retail / Other: 31.52%

Top Institutional Holders

Rosalind Advisors, Inc.
2.91M8.29%
AIGH Capital Management, LLC
2.49M7.09%
Solas Capital Management LLC
2.48M7.08%
BlackRock Inc
1.37M3.90%
Vanguard Capital Management, LLC
897.14K2.56%
Awm Investment Company Inc
720.13K2.05%
Prospect Capital Advisors, LLC
497.80K1.42%
Geode Capital Management, LLC
371.74K1.06%
State Street Corp
359.06K1.02%
Potomac Capital Management, Inc.
224.40K0.64%
Morgan Stanley - Brokerage Accounts
211.11K0.60%
Vanguard Portfolio Management, LLC
168.47K0.48%
Northern Trust Corp
152.12K0.43%
CenterBook Partners LP
118.58K0.34%
Lion Point Capital, LP
112.43K0.32%

Top Fund Holders

Vanguard MStar Total Stk Mkt Idx Invest
815.19K2.32%
iShares Russell 2000 ETF
742.19K2.12%
Fidelity Small Cap Index
314.60K0.90%
iShares Russell 2000 Growth ETF
274.78K0.78%
Vanguard Russell 2000 ETF
166.54K0.47%

Stock Splits

Sep 9, 20141:3
Aug 31, 20111:18
Aug 2, 20051:5